Literature DB >> 8627822

Urolithiasis and cystic fibrosis.

L A Matthews1, C F Doershuk, R C Stern, M I Resnick.   

Abstract

PURPOSE: We determined whether cystic fibrosis patients are at increased risk for the development of urolithiasis.
MATERIALS AND METHODS: Telephone interviews were conducted with 201 cystic fibrosis patients older than 15 years to identify those with a history of urolithiasis. Histories were confirmed by chart review, and only patients with urolithiasis documented by excretory urography, renal ultrasound or spontaneous passage of a stone were included.
RESULTS: A total of 11 patients (5.5%) had documented urolithiasis, with 2 or more episodes in 7. Mean age at initial episode was 27.0 years (range 19 to 33).
CONCLUSIONS: Cystic fibrosis patients may be at increased risk for urolithiasis compared to age-specific prevalence rates for stone disease in the general population.

Entities:  

Mesh:

Year:  1996        PMID: 8627822

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  8 in total

1.  DNA sequencing and expression of the formyl coenzyme A transferase gene, frc, from Oxalobacter formigenes.

Authors:  H Sidhu; S D Ogden; H Y Lung; B G Luttge; A L Baetz; A B Peck
Journal:  J Bacteriol       Date:  1997-05       Impact factor: 3.490

2.  Renal diseases in adults with cystic fibrosis: a 40 year single centre experience.

Authors:  M J Wilcock; A Ruddick; K M Gyi; M E Hodson
Journal:  J Nephrol       Date:  2015-02-25       Impact factor: 3.902

3.  Characterization and heterologous expression of the oxalyl coenzyme A decarboxylase gene from Bifidobacterium lactis.

Authors:  Federica Federici; Beatrice Vitali; Roberto Gotti; Maria Rosalia Pasca; Silvia Gobbi; Ammon B Peck; Patrizia Brigidi
Journal:  Appl Environ Microbiol       Date:  2004-09       Impact factor: 4.792

4.  Heterologous expression of oxalate decarboxylase in Lactobacillus plantarum NC8.

Authors:  Anbazhagan Kolandaswamy; Leema George; Selvam Sadasivam
Journal:  Curr Microbiol       Date:  2008-10-23       Impact factor: 2.188

Review 5.  Oxalate-degrading microorganisms or oxalate-degrading enzymes: which is the future therapy for enzymatic dissolution of calcium-oxalate uroliths in recurrent stone disease?

Authors:  Ammon B Peck; Benjamin K Canales; Cuong Q Nguyen
Journal:  Urolithiasis       Date:  2015-12-08       Impact factor: 3.436

6.  Loss of Cystic Fibrosis Transmembrane Regulator Impairs Intestinal Oxalate Secretion.

Authors:  Felix Knauf; Robert B Thomson; John F Heneghan; Zhirong Jiang; Adedotun Adebamiro; Claire L Thomson; Christina Barone; John R Asplin; Marie E Egan; Seth L Alper; Peter S Aronson
Journal:  J Am Soc Nephrol       Date:  2016-06-16       Impact factor: 10.121

7.  Predisposing factors for nephrolithiasis and nephrocalcinosis in cystic fibrosis.

Authors:  Hamid-Reza Kianifar; Saeedeh Talebi; Mahmoodreza Khazaei; Saeed Talebi; Ali Alamdaran; Simin Hiradfar
Journal:  Iran J Pediatr       Date:  2011-03       Impact factor: 0.364

8.  Secretion of biologically active heterologous oxalate decarboxylase (OxdC) in Lactobacillus plantarum WCFS1 using homologous signal peptides.

Authors:  Ponnusamy Sasikumar; Sivasamy Gomathi; Kolandaswamy Anbazhagan; Govindan Sadasivam Selvam
Journal:  Biomed Res Int       Date:  2013-07-18       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.